| Libya | | |
Prevalence of obesity among children and adolescents (5?19 years) (%) | 14.6% (2016) [26/190countries] | | | Age-standardized prevalence of obesity among adults (18+ years) (%) | 32.5% (2016) [16/190countries] | | |
|
| Libya | | |
New HIV infections (per 1000 uninfected population) | 0.05 (2020) [94/130countries] | | | Tuberculosis incidence (per 100,000 population) | 59.0 (2021) [80/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 0.4 (2020) [72/194countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 18.6 (2019) [102/183countries] | | |
|
| Libya | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 132.2 (2020) [125/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 8.2 (2020) [42/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 3.9 (2020) [65/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 34.6 (2020) [133/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 7.7 (2020) [144/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 13.2 (2020) [94/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 2.7 (2020) [144/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 2.4 (2020) [10/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 3.1 (2020) [82/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 3.0 (2020) [26/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.7 (2020) [77/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.1 (2020) [159/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 4.4 (2020) [121/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 16.6 (2020) [75/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 1.5 (2020) [162/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.4 (2020) [88/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 1.9 (2020) [24/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 6.6 (2020) [93/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.0 (2020) [150/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.2 (2020) [135/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 4.8 (2020) [131/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 4.0 (2020) [86/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 18.6 (2020) [142/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 3.7 (2020) [149/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.6 (2020) [115/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 3.2 (2020) [111/184countries] | | |
|
| Libya | | |
Suicide, age-standardized (per 100 000 population) | 4.49 (2019) [148/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 6.11 (2019) [150/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 2.90 (2019) [119/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 4.05 (2019) [119/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 5.12 (2019) [136/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 2.93 (2019) [77/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 6.60 (2019) [110/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 9.21 (2019) [118/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 3.98 (2019) [62/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 7.70 (2019) [113/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 10.28 (2019) [123/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 5.06 (2019) [62/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 6.69 (2019) [141/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 9.15 (2019) [142/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 4.11 (2019) [109/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 5.34 (2019) [151/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 7.60 (2019) [158/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 3.23 (2019) [129/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 5.55 (2019) [155/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 7.62 (2019) [163/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 3.75 (2019) [130/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 5.63 (2019) [163/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 8.62 (2019) [168/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 3.27 (2019) [145/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 10.66 (2019) [158/183countries] | | |
|
|